Hendrik Nogai
Chief Tech/Sci/R&D Officer chez RYVU THERAPEUTICS S.A.
Profil
Dr. Hendrik Nogai, MD, is a Chief Medical Officer at Ryvu Therapeutics SA. Dr. Nogai was previously employed as a Vice President by Bayer Pharmaceuticals /Switzerland/.
He received his doctorate degree from Ludwig-Maximilians-Universität München, a doctorate degree from Charité - Universitätsmedizin Berlin and a doctorate degree from Harvard Medical School.
Postes actifs de Hendrik Nogai
| Sociétés | Poste | Début |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 01/02/2022 |
Anciens postes connus de Hendrik Nogai
| Sociétés | Poste | Fin |
|---|---|---|
| Bayer Pharmaceuticals /Switzerland/ | Corporate Officer/Principal | 01/01/2022 |
Formation de Hendrik Nogai
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| Charité - Universitätsmedizin Berlin | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Bayer Pharmaceuticals /Switzerland/ |
